Autolus Therapeutics - ADR Financials

$2.11

$-0.13 (-5.80%)

As on 08-Sep-2026 16:00EDT

Market cap

$596 Mln

Revenue (TTM)

$117 Mln

P/E Ratio

--

P/B Ratio

8.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Operating Revenue	117.35	75.56	10.12	1.70	1.70	6.19
Cost of Revenue	98.97	96.59	141.02	6.57	6.57	137.22
Gross Profit	18.38	-21.03	-130.90	1.70	-4.87	6.19
Operating Expenses	265.72	260.41	110.53	181.40	190.16	149.09
Operating Profit (EBIT)	-247.33	-281.44	-241.43	-179.70	-195.03	-142.89
Other Income	--	--	--	--	--	--
Profit before Tax	-279.35	-296.85	-219.13	-208.40	-208.40	-148.57
Provision for Tax	0.68	-8.65	1.53	-0.02	-0.02	0.27
Profit after Tax (Net Income)	-280.03	-288.20	-220.66	-208.38	-208.38	-148.84
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-148.84

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Shareholder's Funds	74.84	178.13	427.33	111.47	111.47	298.67
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	349.60	337.50	294.66	219.17	219.17	145.23
Current Liabilities	68.79	73.44	60.74	44.74	44.74	46.37
Total Liabilities	562.02	589.07	782.73	375.38	375.38	490.27

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Non-Current Assets	157.14	153.15	121.80	100.08	100.08	64.50
Current Assets	336.09	435.92	660.93	275.30	275.30	425.77
Total Assets	562.02	589.07	782.73	375.38	375.38	490.27
Total Debt*	83.51	351.59	52.63	52.97	52.97	24.26
Net Current Assets	267.30	362.48	600.19	230.57	230.57	379.41

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Cash From Operating Activities	--	-283.57	-206.27	-145.59	-145.59	-112.31
Cash Flow from Investing Activities	--	158.46	-394.55	-10.99	--	-10.84
Cash from Financing Activities	--	-4.34	589.55	-0.88	-0.88	223.61
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Adjusted EPS ($)	-1.05	-1.08	-0.83	-1.20	-1.20	-1.27
Cash EPS ($)	--	-1.05	-0.80	-1.16	-1.16	-1.21
Adjusted Book Value ($)	--	0.67	1.61	0.64	0.64	2.55
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.07	-0.78	-0.84	-0.84	-0.96
Free Cash Flow per Share ($)	--	-1.17	-0.91	-0.90	-0.90	-1.05

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
ROCE (%)	--	-57.09	-68.49	-126.72	-85.51	-46.09
ROE (%)	-221.39	-95.20	-81.91	-186.93	-101.61	-49.83
ROA (%)	-41.45	-42.02	-38.11	-55.51	-48.14	-30.36
EBIT Margin (%)	-197.90	-344.20	-2,379.34	-9,619.26	-11,485.75	-2,254.79
Net Margin (%)	-238.62	-381.40	-2,180.45	-12,272.26	-12,272.26	-2,402.95
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Revenue Growth (%)	292.05	6.47	4.96	-0.73	-0.73	3.11
EBIT Growth (%)	6.66	-8.02	-47.42	-16.95	-19.08	0.90
Net Profit Growth (%)	-22.94	-30.61	-5.89	-40.01	-40.01	-4.75
EPS Growth (%)	-22.93	-0.31	0.31	0.06	0.27	0.35
Book Value Growth (%)	-78.40	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Price / Earnings	--	-1.84	-2.83	-5.38	-1.95	-1.50
Price / Book Value	8.14	2.97	1.46	10.05	3.64	0.75
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.03	-2.32	-0.39	-5.96	-1.16	1.02
Close Price ($)	1.60	1.99	2.35	6.44	2.33	1.90
High Price ($)	2.70	2.80	7.45	6.94	3.54	5.59
Low Price ($)	1.18	1.11	2.07	1.61	1.60	1.60
Market Cap ($ Cr)	596.20	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Debt to Equity	--	1.97	0.12	0.48	0.48	0.08
Short term debt to equity ratio	0.08	0.08	0.01	0.05	0.05	0.02
Current Ratio	4.89	5.94	10.88	6.15	6.15	9.18
Quick Ratio	4.40	5.48	10.81	6.68	6.70	8.88
Interest Coverage	-4.93	-7.08	-25.91	-3.62	-4.33	-15.68

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Debtors to sales (%)	37.83	100.30	476.68	61.66	1,445.35	467.81
Asset Turnover	0.17	0.11	0.02	0.00	0.00	0.01
Receivable days	--	299.76	889.43	2,752.17	5,756.02	1,708.67
Inventory Days	--	70.61	-25.07	-1,336.29	-288.92	37.68
Payable days	--	9.55	2.68	5.73	17.64	1.41
Cash Conversion Cycle	--	360.81	861.68	1,410.15	5,449.47	1,744.93

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.